 | Up a level |
Orrell, C, Kintu, K, Coombs, JA, Amara, A, Myer, L, Kaboggoza, J 
ORCID: 0000-0001-9510-0474, Simmons, B, Else, L, Heiberg, C, Waitt, C et al (show 5 more authors)
(2018)
DolPHIN-1: Randomised controlled trial of dolutegravir (DTG)- versus efavirenz (EFV)-based therapy in mothers initiating antiretroviral treatment in late pregnancy.
.
Dickinson, Laura, Amin, J, Else, Laura, Boffito, M, Egan, Deirdre, Owen, Andrew ORCID: 0000-0002-9819-7651, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Orrell, C, Clarke, A et al (show 6 more authors)
(2015)
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study.
Clinical pharmacology and therapeutics, 98 (4).
pp. 406-416.